MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1093/ejcts/ezy333

Медицинская библиотека · European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery · 2019

Outcomes after transaortic transcatheter aortic valve implantation: long-term findings from the European ROUTE†.

Cocchieri Riccardo, Petzina Rainer, Romano Mauro, Jagielak Dariusz, Bonaros Nikolaos, Aiello Marco, Lapeze Joel, Laine Mika, Chocron Sidney, Muir Douglas, Eichinger Walter, Thielmann Matthias, Labrousse Louis, Rein Kjell Arne, Verhoye Jean-Philippe, Gerosa Gino, Bapat Vinayak, Baumbach Hardy, Sims Helen, Deutsch Cornelia, Bramlage Peter, Kurucova Jana, Thoenes Martin, Frank Derk

СтатьяМногоцентровое исследованиеНаблюдательное исследованиеПеревод в очереди

Аннотация

OBJECTIVES

There is lack of data regarding the longer-term outcomes of patients undergoing transaortic (TAo) transcatheter aortic valve implantation (TAVI). We aimed to provide a contemporary snapshot of the types and frequencies of events in the year following TAo-TAVI.

METHODS

The Registry of the Utilization of the TAo-TAVI approach using the Edwards SAPIEN Valve (ROUTE) is a multicentre, European, prospective, observational registry of aortic stenosis patients undergoing TAo-TAVI. Patients were grouped according to the composite end point death, myocardial infarction, stroke/transient ischaemic attack, major vascular complications, life-threatening bleeding, acute kidney injury (AKI) and/or cardiovascular rehospitalization.

RESULTS

Two hundred and fifty-three patients with a mean age of 81.5 ± 5.8 years were included, of whom 89 (35.2%) patients met the composite end point (the event group) and 164 (64.8%) patients did not (the event-free group). New York Heart Association (NYHA) class III/IV (85.2% vs 71.8%, P = 0.017), Canadian Cardiovascular Society angina class III/IV (22.6% vs 11.4%; P = 0.021), pulmonary disease (32.6% vs 18.9%; P = 0.015) and renal insufficiency (15.7% vs 3.0%; P < 0.001) were more common in the event group. At 1 year, the most common event was death (19.1%), followed by AKI stage II or III (14.7%). The baseline renal insufficiency was the strongest independent predictor of composite end point achievement [odds ratio (OR) 7.55, 95% confidence interval (CI) 2.33-24.56], followed by NYHA class III/IV (OR 2.316, 95% CI 1.06-5.06) and pulmonary disease (OR 2.91, 95% CI 1.45-5.85). Pulmonary disease was also an independent predictor of 1-year mortality (OR 3.01, 95% CI 1.34-6.75).

CONCLUSIONS

Long-term outcomes after TAo-TAVI appear to be similar to those for TAVI via other non-transfemoral access routes. Awareness of characteristics associated with poorer outcomes may aid patient selection and identification of those requiring closer post-procedural monitoring.

CLINICAL TRIAL REGISTRATION NUMBER: ClinicalTrials.gov identifier: NCT01991431.

Для цитирования: Cocchieri Riccardo, Petzina Rainer, Romano Mauro, Jagielak Dariusz, Bonaros Nikolaos, Aiello Marco, Lapeze Joel, Laine Mika, Chocron Sidney, Muir Douglas, Eichinger Walter, Thielmann Matthias, Labrousse Louis, Rein Kjell Arne, Verhoye Jean-Philippe, Gerosa Gino, Bapat Vinayak, Baumbach Hardy, Sims Helen, Deutsch Cornelia, Bramlage Peter, Kurucova Jana, Thoenes Martin, Frank Derk. Outcomes after transaortic transcatheter aortic valve implantation: long-term findings from the European ROUTE†.. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery. 2019. DOI: 10.1093/ejcts/ezy333.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.